7 completed. 7 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Completed 7 |
| Phase 2 | 1 | Completed 1 |
Follow Vaccine: new trials by email Literature Review of Vaccine trials Research Report on Vaccine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Immune Response of a Rabies Vaccine With the Essen Schedule and a Two-Dose Booster the tested vaccine, the control vaccine - Vaccine | Phase 3 | Completed | Jiangsu Province Centers for Disease Control and Prevention | 1200 | 2022-07-19 | 2026-06-29 |
| Persistence and Long-Term Protection of Vi Antibodies Induced by Vi-DT Conjugate Vaccines in Indonesian Vi-DT Typhoid Conjugate Vaccine - Vaccine | Phase 2 / Phase 3 | Completed | PT Bio Farma | 188 | 2021-05-03 | 2025-06-03 |
| Immunogenicity and Safety of Bivalent Meningococcal Serogroups A and C Tetanus Toxoid Conjugate Vaccine in Chinese experimental vaccine, Positive control vaccine 1, Positive control vaccine 2 - Vaccine | Phase 3 | Completed | Jiangsu Province Centers for Disease Control and Prevention | 1950 | 2016-05-12 | 2018-10-22 |
| A Study to Assess the Safety of ASP7374 in Adult Subjects Aged 20 or Older ASP7374 - Influenza, Vaccine | Phase 3 | Completed | UMN Pharma Inc. | 55 | 2015-02-01 | 2017-09-29 |
| Study of ASP7374, Cell-culture-derived Influenza Vaccine ASP7374, approved egg-derived TIV - Influenza, Vaccine | Phase 3 | Completed | UMN Pharma Inc. | 900 | 2013-10-01 | 2017-09-29 |
| A Study to Evaluate Intramuscular ASP7374 ASP7374 - Influenza, Vaccine | Phase 3 | Completed | UMN Pharma Inc. | 55 | 2013-10-01 | 2017-09-29 |
| Safety and Immunogenicity of Trivalent Split Influenza Vaccine Using the Strain Composition 2007/2008 trivalent split influenza vaccine - Seasonal Influenza, Vaccine | Phase 3 | Completed | Novartis | 120 | 2007-06-01 | 2008-04-22 |
Influenza, Human (4)
Infections (4) · Orthomyxoviridae Infections (4) · RNA Virus Infections (4) · Respiratory Tract Diseases (4) · Respiratory Tract Infections (4) · Virus Diseases (4)
UMN Pharma Inc. (3) · Jiangsu Province Centers for Disease Control and Prevention (2) · Novartis (1) · PT Bio Farma (1)
Japan (3) · China (1) · Germany (1) · Indonesia (1)